273 related articles for article (PubMed ID: 29548334)
1. Influence of cell type and cell culture media on the propagation of foot-and-mouth disease virus with regard to vaccine quality.
Dill V; Hoffmann B; Zimmer A; Beer M; Eschbaumer M
Virol J; 2018 Mar; 15(1):46. PubMed ID: 29548334
[TBL] [Abstract][Full Text] [Related]
2. Adaption of FMDV Asia-1 to Suspension Culture: Cell Resistance Is Overcome by Virus Capsid Alterations.
Dill V; Hoffmann B; Zimmer A; Beer M; Eschbaumer M
Viruses; 2017 Aug; 9(8):. PubMed ID: 28820470
[TBL] [Abstract][Full Text] [Related]
3. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
Xu W; Zhang Z; Nfon C; Yang M
Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
[TBL] [Abstract][Full Text] [Related]
4. Investigation of cell culture conditions for optimal foot-and-mouth disease virus production.
Dill V; Zimmer A; Beer M; Eschbaumer M
BMC Biotechnol; 2019 Jun; 19(1):33. PubMed ID: 31174517
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus.
Chamberlain K; Fowler VL; Barnett PV; Gold S; Wadsworth J; Knowles NJ; Jackson T
J Gen Virol; 2015 Sep; 96(9):2684-2692. PubMed ID: 26296881
[TBL] [Abstract][Full Text] [Related]
6. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
[TBL] [Abstract][Full Text] [Related]
7. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
[TBL] [Abstract][Full Text] [Related]
8. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
[TBL] [Abstract][Full Text] [Related]
10. Development of a universal RT-PCR for amplifying and sequencing the leader and capsid-coding region of foot-and-mouth disease virus.
Xu L; Hurtle W; Rowland JM; Casteran KA; Bucko SM; Grau FR; Valdazo-González B; Knowles NJ; King DP; Beckham TR; McIntosh MT
J Virol Methods; 2013 Apr; 189(1):70-6. PubMed ID: 23380590
[TBL] [Abstract][Full Text] [Related]
11. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
12. Recombination of host cell mRNA with the Asia 1 foot-and-mouth disease virus genome in cell suspension culture.
Zou X; Zhu Y; Bao H; Guo X; Sun P; Liu Z; Mason PW; Xu L; Li C; Zhang Q; Wang Q; Zhu H; Zhao Q
Arch Virol; 2019 Jan; 164(1):41-50. PubMed ID: 30232612
[TBL] [Abstract][Full Text] [Related]
13. Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris.
Balamurugan V; Renji R; Saha SN; Reddy GR; Gopalakrishna S; Suryanarayana VV
Virus Res; 2003 Apr; 92(2):141-9. PubMed ID: 12686422
[TBL] [Abstract][Full Text] [Related]
14. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
15. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
16. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
[TBL] [Abstract][Full Text] [Related]
17. The pH stability of foot-and-mouth disease virus.
Yuan H; Li P; Ma X; Lu Z; Sun P; Bai X; Zhang J; Bao H; Cao Y; Li D; Fu Y; Chen Y; Bai Q; Zhang J; Liu Z
Virol J; 2017 Nov; 14(1):233. PubMed ID: 29183342
[TBL] [Abstract][Full Text] [Related]
18. Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: influence of receptor usage on the properties of virus particles.
Maree FF; Blignaut B; Aschenbrenner L; Burrage T; Rieder E
Virus Res; 2011 Feb; 155(2):462-72. PubMed ID: 21167231
[TBL] [Abstract][Full Text] [Related]
19. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.
Kotecha A; Zhang F; Juleff N; Jackson T; Perez E; Stuart D; Fry E; Charleston B; Seago J
J Gen Virol; 2016 Jul; 97(7):1557-1565. PubMed ID: 27002540
[TBL] [Abstract][Full Text] [Related]
20. Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension.
Rizvi A; Hussain N; Anjum AA; Ahmed N; Naeem A; Khan M; Altaf I
J Virol Methods; 2022 Feb; 300():114379. PubMed ID: 34826516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
